Rossari biotech
0
Anand Rathi has given a ‘Buy’ rating to Rossari Biotech shares, setting a target price of ₹950, which suggests a 26% increase from Thursday’s closing price....
Anand Rathi has given a ‘Buy’ rating to Rossari Biotech shares, setting a target price of ₹950, which suggests a 26% increase from Thursday’s closing price....